Genetic variation in susceptibility as a key parameter in risk assessment and risk communication: policy aspects.
Omenn
G S
GS
School of Public Health and Community Medicine, University of Washington, Seattle 98195-7230, USA.
D000818:Animals; D015415:Biomarkers; D001711:Biotransformation / Q000235:genetics; D004798:Enzymes / Q000235:genetics; D016147:Genes, Tumor Suppressor; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000235:genetics / Q000517:prevention & control; D009857:Oncogenes; D051381:Rats; D018570:Risk Assessment; D012377:Rodentia / Q000235:genetics; D013045:Species Specificity; D014481:United States
D015415:Biomarkers; D004798:Enzymes